Selisistat Market In Global
Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is ... Read More
IBMX is a widely-used non-specific inhibitor of cyclic AMP and cyclic GMP phosphodiesterases (PDEs).
This report contains market size and forecasts of Isobutylmethylxanthine(IBMX) in global, including the following market information:
Global Isobutylmethylxanthine(IBMX) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Isobutylmethylxanthine(IBMX) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Isobutylmethylxanthine(IBMX) companies in 2021 (%)
The global Isobutylmethylxanthine(IBMX) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Isobutylmethylxanthine(IBMX) include Thermo Fisher Scientific, Abcam, Merck, Cayman Chemical, Santa Cruz Biotechnology, BioVision, Focus Biomolecules, STEMCELL Technologies and Selleck Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Isobutylmethylxanthine(IBMX) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Isobutylmethylxanthine(IBMX) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Isobutylmethylxanthine(IBMX) Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Isobutylmethylxanthine(IBMX) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Isobutylmethylxanthine(IBMX) Market Segment Percentages, by Application, 2021 (%)
Research
Biopharmaceutical
Global Isobutylmethylxanthine(IBMX) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Isobutylmethylxanthine(IBMX) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Isobutylmethylxanthine(IBMX) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Isobutylmethylxanthine(IBMX) revenues share in global market, 2021 (%)
Key companies Isobutylmethylxanthine(IBMX) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Isobutylmethylxanthine(IBMX) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Abcam
Merck
Cayman Chemical
Santa Cruz Biotechnology
BioVision
Focus Biomolecules
STEMCELL Technologies
Selleck Chemicals
BPS Bioscience
Enzo Biochem
Adipogen Life Sciences
AbMole BioScience
Cell Signaling Technology
Beyotime
Shanghai Maokang Biotechnology
Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is ... Read More
Geldanamycin is an antibiotic and a potent antitumor compound. It inhibits pp60src tyrosine kinas ... Read More
Tunicamycin is a mixture of homologous nucleoside antibiotic that inhibits N-linked glycosylatio ... Read More
Epoxomicin is an epoxyketone-containing natural product and a potent, selective and irreversible ... Read More